A Smarter Workforce Strategy
Companies are under constant pressure to accelerate drug development while managing tight budgets and headcount restrictions. Many turn to temporary staffing, but this model often falls short for long-term needs.
Traditional temporary staffing is best suited for short-term gaps, such as maternity leave or project-related surges. This staffing type comes with significant limitations: contracts are typically capped at 6–24 months to mitigate co-employment risk, and clients must manage training, supervision, and HR functions. High turnover and retraining costs further reduce efficiency and morale.
In contrast, PSS hires, trains, and manages full-time scientific staff who work on-site using the client’s equipment, systems and SOPs. PSS teams are supported by on-site leadership and have access to Eurofins’ global technical network. This model eliminates co-employment risks, reduces HR burden, and ensures business continuity, while delivering superlative service with measurable KPIs and Operational Excellence value-add programs that have saved clients over $37 million since 2017. Another added benefit: PSS employees receive comprehensive benefits and career development, resulting in higher retention and performance.
For bio/pharma companies seeking to maintain productivity, business continuity, reduce risk, and control costs, PSS offers a superior alternative to traditional temp staffing. With a proven track record, global reach, and client-first approach, PSS enables organizations to meet their scientific and operational goals—without compromising compliance or quality.
Insourcing vs. Temp Staffing: A Strategic Comparison
